Wikipedia -WSS

Wikipedia

author：fashion 2025-09-14 11:44:08 - browse：6984

Fiona Marshall, president of the Novartis research hub in Cambridge, Mass., speaks Thursday during the STAT Future Summit. STAT

Swiss drugmaker Novartis’ research and development hub has a new name — and a new guiding strategy.

The hub, which is headquartered in Cambridge, Mass., and for years has been known as Novartis Institutes for BioMedical Research, or NIBR, will soon simply be known as Novartis Biomedical Research.

But that’s not the only thing that’s changing, Fiona Marshall, the hub’s president, told a virtual audience Thursday during the 2023 STAT Future Summit. The new name reflects a larger shift by the pharma giant to retool its research strategy — from one driven by the pure pursuit of scientific discovery to a tighter focus on projects likely to yield commercially successful drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Telehealth startups turn to complex chronic diseases

entertainment

WSS

Use wet bulb globe temperature, not heat index, to protect workers

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Study: AI not yet building 'n

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Weight loss drugs aren’t covered by Obamacare. That may change

Study: AI not yet building 'n

focus

Wikipedia

knowledge

Heart attack and stroke risk calculators need revising

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Cancer drug shortages should be causing more outrage

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Activists slam private health insurers over coverage restrictions

Apple Watch's A

Hollywood unions extend contract negotiations for actors

Brain worms: The science behind RFK Jr.'s parasitic infection

How to save PrEP access — and even expand it

Elevance, SCAN deals highlight health insurer acquisition scrutiny

focus

A new drug could help frostbite victims avoid its ravages

Telehealth startups turn to complex chronic diseases

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Making AI in medicine accessible to smaller, and rural hospitals

Measles policy set amid Florida outbreak alarms vaccine proponents

entertainment

knowledge

leisure time

focus